These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
333 related articles for article (PubMed ID: 25157892)
1. Dichloroacetate and cancer: new home for an orphan drug? Kankotia S; Stacpoole PW Biochim Biophys Acta; 2014 Dec; 1846(2):617-29. PubMed ID: 25157892 [TBL] [Abstract][Full Text] [Related]
2. Activation of mitochondrial oxidation by PDK2 inhibition reverses cisplatin resistance in head and neck cancer. Roh JL; Park JY; Kim EH; Jang HJ; Kwon M Cancer Lett; 2016 Feb; 371(1):20-9. PubMed ID: 26607904 [TBL] [Abstract][Full Text] [Related]
3. Inactivation of the HIF-1α/PDK3 signaling axis drives melanoma toward mitochondrial oxidative metabolism and potentiates the therapeutic activity of pro-oxidants. Kluza J; Corazao-Rozas P; Touil Y; Jendoubi M; Maire C; Guerreschi P; Jonneaux A; Ballot C; Balayssac S; Valable S; Corroyer-Dulmont A; Bernaudin M; Malet-Martino M; de Lassalle EM; Maboudou P; Formstecher P; Polakowska R; Mortier L; Marchetti P Cancer Res; 2012 Oct; 72(19):5035-47. PubMed ID: 22865452 [TBL] [Abstract][Full Text] [Related]
4. Sodium dichloroacetate selectively targets cells with defects in the mitochondrial ETC. Stockwin LH; Yu SX; Borgel S; Hancock C; Wolfe TL; Phillips LR; Hollingshead MG; Newton DL Int J Cancer; 2010 Dec; 127(11):2510-9. PubMed ID: 20533281 [TBL] [Abstract][Full Text] [Related]
5. Dichloroacetate metabolically targeted therapy defeats cytotoxicity of standard anticancer drugs. Heshe D; Hoogestraat S; Brauckmann C; Karst U; Boos J; Lanvers-Kaminsky C Cancer Chemother Pharmacol; 2011 Mar; 67(3):647-55. PubMed ID: 20502900 [TBL] [Abstract][Full Text] [Related]
6. Dual-targeting of aberrant glucose metabolism in glioblastoma. Shen H; Decollogne S; Dilda PJ; Hau E; Chung SA; Luk PP; Hogg PJ; McDonald KL J Exp Clin Cancer Res; 2015 Feb; 34(1):14. PubMed ID: 25652202 [TBL] [Abstract][Full Text] [Related]
7. Overexpression of pyruvate dehydrogenase kinase supports dichloroacetate as a candidate for cutaneous melanoma therapy. Pópulo H; Caldas R; Lopes JM; Pardal J; Máximo V; Soares P Expert Opin Ther Targets; 2015 Jun; 19(6):733-45. PubMed ID: 25976231 [TBL] [Abstract][Full Text] [Related]
8. Antitumor and chemosensitizing action of dichloroacetate implicates modulation of tumor microenvironment: a role of reorganized glucose metabolism, cell survival regulation and macrophage differentiation. Kumar A; Kant S; Singh SM Toxicol Appl Pharmacol; 2013 Nov; 273(1):196-208. PubMed ID: 24051182 [TBL] [Abstract][Full Text] [Related]
9. Acidosis-induced metabolic reprogramming in tumor cells enhances the anti-proliferative activity of the PDK inhibitor dichloroacetate. Schoonjans CA; Joudiou N; Brusa D; Corbet C; Feron O; Gallez B Cancer Lett; 2020 Feb; 470():18-28. PubMed ID: 31812695 [TBL] [Abstract][Full Text] [Related]
10. The effect of dichloroacetate in canine prostate adenocarcinomas and transitional cell carcinomas in vitro. Harting T; Stubbendorff M; Willenbrock S; Wagner S; Schadzek P; Ngezahayo A; Murua Escobar HM; Nolte I Int J Oncol; 2016 Dec; 49(6):2341-2350. PubMed ID: 27748833 [TBL] [Abstract][Full Text] [Related]
11. Targeting of two aspects of metabolism in breast cancer treatment. Gang BP; Dilda PJ; Hogg PJ; Blackburn AC Cancer Biol Ther; 2014; 15(11):1533-41. PubMed ID: 25482950 [TBL] [Abstract][Full Text] [Related]
13. Dichloroacetate enhances apoptotic cell death via oxidative damage and attenuates lactate production in metformin-treated breast cancer cells. Haugrud AB; Zhuang Y; Coppock JD; Miskimins WK Breast Cancer Res Treat; 2014 Oct; 147(3):539-50. PubMed ID: 25212175 [TBL] [Abstract][Full Text] [Related]
14. Sensitization of metformin-cytotoxicity by dichloroacetate via reprogramming glucose metabolism in cancer cells. Choi YW; Lim IK Cancer Lett; 2014 May; 346(2):300-8. PubMed ID: 24480191 [TBL] [Abstract][Full Text] [Related]
15. Dichloroacetate and Pyruvate Metabolism: Pyruvate Dehydrogenase Kinases as Targets Worth Investigating for Effective Therapy of Toxoplasmosis. Ferrarini MG; Nisimura LM; Girard RMBM; Alencar MB; Fragoso MSI; Araújo-Silva CA; Veiga AA; Abud APR; Nardelli SC; Vommaro RC; Silber AM; France-Sagot M; Ávila AR mSphere; 2021 Jan; 6(1):. PubMed ID: 33408226 [TBL] [Abstract][Full Text] [Related]
16. Dichloroacetate shifts the metabolism from glycolysis to glucose oxidation and exhibits synergistic growth inhibition with cisplatin in HeLa cells. Xie J; Wang BS; Yu DH; Lu Q; Ma J; Qi H; Fang C; Chen HZ Int J Oncol; 2011 Feb; 38(2):409-17. PubMed ID: 21132264 [TBL] [Abstract][Full Text] [Related]
17. Targeted reversal and phosphorescence lifetime imaging of cancer cell metabolism via a theranostic rhenium(I)-DCA conjugate. Yang J; Cao Q; Zhang H; Hao L; Zhou D; Gan Z; Li Z; Tong YX; Ji LN; Mao ZW Biomaterials; 2018 Sep; 176():94-105. PubMed ID: 29870900 [TBL] [Abstract][Full Text] [Related]